These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21367981)

  • 1. A critical threshold of meningococcal factor H binding protein expression is required for increased breadth of protective antibodies elicited by native outer membrane vesicle vaccines.
    Koeberling O; Delany I; Granoff DM
    Clin Vaccine Immunol; 2011 May; 18(5):736-42. PubMed ID: 21367981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Meningococcal Outer Membrane Vesicle Vaccine with Overexpressed Mutant FHbp Elicits Higher Protective Antibody Responses in Infant Rhesus Macaques than a Licensed Serogroup B Vaccine.
    Beernink PT; Vianzon V; Lewis LA; Moe GR; Granoff DM
    mBio; 2019 Jun; 10(3):. PubMed ID: 31213564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Meningococcal Native Outer Membrane Vesicle Vaccine With Attenuated Endotoxin and Overexpressed Factor H Binding Protein Elicits Gonococcal Bactericidal Antibodies.
    Beernink PT; Ispasanie E; Lewis LA; Ram S; Moe GR; Granoff DM
    J Infect Dis; 2019 Mar; 219(7):1130-1137. PubMed ID: 30346576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of human factor H on immunogenicity of meningococcal native outer membrane vesicle vaccines with over-expressed factor H binding protein.
    Beernink PT; Shaughnessy J; Pajon R; Braga EM; Ram S; Granoff DM
    PLoS Pathog; 2012; 8(5):e1002688. PubMed ID: 22589720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A meningococcal NOMV-FHbp vaccine for Africa elicits broader serum bactericidal antibody responses against serogroup B and non-B strains than a licensed serogroup B vaccine.
    Pajon R; Lujan E; Granoff DM
    Vaccine; 2016 Jan; 34(5):643-649. PubMed ID: 26709637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A native outer membrane vesicle vaccine confers protection against meningococcal colonization in human CEACAM1 transgenic mice.
    Pajon R; Buckwalter CM; Johswich KO; Gray-Owen SD; Granoff DM
    Vaccine; 2015 Mar; 33(11):1317-1323. PubMed ID: 25662856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meningococcal outer membrane vesicle vaccines derived from mutant strains engineered to express factor H binding proteins from antigenic variant groups 1 and 2.
    Koeberling O; Giuntini S; Seubert A; Granoff DM
    Clin Vaccine Immunol; 2009 Feb; 16(2):156-62. PubMed ID: 19109451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of a meningococcal native outer membrane vesicle vaccine with attenuated endotoxin and over-expressed factor H binding protein in infant rhesus monkeys.
    Koeberling O; Seubert A; Santos G; Colaprico A; Ugozzoli M; Donnelly J; Granoff DM
    Vaccine; 2011 Jun; 29(29-30):4728-34. PubMed ID: 21571025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meningococcal factor H binding proteins in epidemic strains from Africa: implications for vaccine development.
    Pajon R; Fergus AM; Koeberling O; Caugant DA; Granoff DM
    PLoS Negl Trop Dis; 2011 Sep; 5(9):e1302. PubMed ID: 21909444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa.
    Pajon R; Fergus AM; Granoff DM
    PLoS One; 2013; 8(6):e66536. PubMed ID: 23805230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of factor H-Binding protein sequence to the cross-reactivity of meningococcal native outer membrane vesicle vaccines with over-expressed fHbp variant group 1.
    Marini A; Rossi O; Aruta MG; Micoli F; Rondini S; Guadagnuolo S; Delany I; Henderson IR; Cunningham AF; Saul A; MacLennan CA; Koeberling O
    PLoS One; 2017; 12(7):e0181508. PubMed ID: 28742866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the immunogenicity of a trivalent Neisseria meningitidis native outer membrane vesicle vaccine by genetic modification.
    Zhang L; Wen Z; Lin J; Xu H; Herbert P; Wang XM; Mehl JT; Ahl PL; Dieter L; Russell R; Kosinski MJ; Przysiecki CT
    Vaccine; 2016 Jul; 34(35):4250-4256. PubMed ID: 27269057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human factor H (FH) impairs protective meningococcal anti-FHbp antibody responses and the antibodies enhance FH binding.
    Costa I; Pajon R; Granoff DM
    mBio; 2014 Aug; 5(5):e01625-14. PubMed ID: 25161192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A broadly-protective vaccine against meningococcal disease in sub-Saharan Africa based on generalized modules for membrane antigens (GMMA).
    Koeberling O; Ispasanie E; Hauser J; Rossi O; Pluschke G; Caugant DA; Saul A; MacLennan CA
    Vaccine; 2014 May; 32(23):2688-95. PubMed ID: 24704334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meningococcal factor H binding protein mutant that eliminates factor H binding enhances protective antibody responses to vaccination.
    Beernink PT; Shaughnessy J; Braga EM; Liu Q; Rice PA; Ram S; Granoff DM
    J Immunol; 2011 Mar; 186(6):3606-14. PubMed ID: 21325619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does binding of complement factor H to the meningococcal vaccine antigen, factor H binding protein, decrease protective serum antibody responses?
    Granoff DM; Ram S; Beernink PT
    Clin Vaccine Immunol; 2013 Aug; 20(8):1099-107. PubMed ID: 23740919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meningococcal factor H-binding protein vaccines with decreased binding to human complement factor H have enhanced immunogenicity in human factor H transgenic mice.
    Rossi R; Granoff DM; Beernink PT
    Vaccine; 2013 Nov; 31(46):5451-7. PubMed ID: 24035433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of Complement Factor H (FH) Decreases Protective Anti-FH Binding Protein Antibody Responses of Infant Rhesus Macaques Immunized With a Meningococcal Serogroup B Vaccine.
    Granoff DM; Costa I; Konar M; Giuntini S; Van Rompay KK; Beernink PT
    J Infect Dis; 2015 Sep; 212(5):784-92. PubMed ID: 25676468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bactericidal antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed factor H-binding protein and genetically attenuated endotoxin.
    Koeberling O; Seubert A; Granoff DM
    J Infect Dis; 2008 Jul; 198(2):262-70. PubMed ID: 18505380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of inhibition of binding of complement factor H for serum bactericidal antibody responses to meningococcal factor H-binding protein vaccines.
    Konar M; Granoff DM; Beernink PT
    J Infect Dis; 2013 Aug; 208(4):627-36. PubMed ID: 23715659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.